U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07059143) titled '6 Weeks Right-Amygdala TIS for Depression' on July 01.
Brief Summary: The current investigation employs a directed neuromodulation technique, specifically targeting the right amygdala, to ascertain its therapeutic efficacy in managing depressive episodes. The intervention's safety and efficacy will be evaluated using an assessment incorporating depressive symptomatology, cognitive abilities, and daily functions.
Study Start Date: May 27
Study Type: INTERVENTIONAL
Condition:
Major Depressive Disorder (MDD)
Intervention:
DEVICE: Nervio-X
An 8-channel TIS device developed by NEURODOME Corporation.
Recruitment Status: ENROLLING_...